Argent BioPharma secures A$11m facility to complete AusCann acquisition by Adam Sheldon November 17, 2025November 17, 2025 Argent BioPharma has secured an A$11 million funding facility to complete its acquisition of AusCann Group […]
Argent BioPharma inks deal to acquire AusCann assets and IP by Martin Lane August 19, 2025August 21, 2025
Argent Biopharma and Auscann sign deal to ‘enhance drug development’ by Steve Jones April 23, 2025April 23, 2025
Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth by Steve Jones March 7, 2024March 7, 2024
MGC Pharma flags restructure in face of ‘dire alternatives’ by Martin Lane September 26, 2023September 28, 2023
Company news: Little Green Pharma; MGC Pharma; Medlab Clinical; Creso Pharma by Martin Lane February 9, 2023April 29, 2024
Company news: Althea; Cann Group; Emyria; Neurotech; Bod Science; Elixinol; Creso Pharma; MGC Pharma by Steve Jones and Martin Lane January 31, 2023February 2, 2023
